Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 6
2005 9
2006 9
2007 18
2008 17
2009 19
2010 14
2011 15
2012 15
2013 24
2014 19
2015 21
2016 30
2017 35
2018 29
2019 23
2020 20
2021 31
2022 20
2023 22
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

343 results

Results by year

Filters applied: . Clear all
Page 1
The 2020 revision of the guidelines for the management of myeloproliferative neoplasms.
Kim SY, Bae SH, Bang SM, Eom KS, Hong J, Jang S, Jung CW, Kim HJ, Kim HY, Kim MK, Kim SJ, Mun YC, Nam SH, Park J, Won JH, Choi CW. Kim SY, et al. Among authors: kim mk. Korean J Intern Med. 2021 Jan;36(1):45-62. doi: 10.3904/kjim.2020.319. Epub 2020 Dec 4. Korean J Intern Med. 2021. PMID: 33147902 Free PMC article. Review.
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Yun HJ; KCSG TRIUMPH Investigators. Keam B, et al. Among authors: kim mk. J Clin Oncol. 2024 Feb 10;42(5):507-517. doi: 10.1200/JCO.22.02786. Epub 2023 Sep 12. J Clin Oncol. 2024. PMID: 37699162 Clinical Trial.
Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea.
Kim DJ, Jeong S, Kong SG, Lee S, Lim SN, Oh SY, Do YR, Lee WS, Lee MH, Bae SH, Kim SH, Kim MK, Lee HS; Consortium for Improving Survival of Lymphoma (CISL). Kim DJ, et al. Among authors: kim mk. Sci Rep. 2023 Feb 13;13(1):2551. doi: 10.1038/s41598-023-27465-y. Sci Rep. 2023. PMID: 36781859 Free PMC article.
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea.
Kim JS, Jang JH, Jo DY, Ahn SY, Yoon SS, Lee JH, Kim SH, Choi CW, Shin HJ, Kim MK, Lee JH, Mun YC, Kong JH, Hyun B, Nam H, Kim E, Kwak MJ, Won YK, Lee JW. Kim JS, et al. Among authors: kim mk. J Korean Med Sci. 2023 Oct 23;38(41):e328. doi: 10.3346/jkms.2023.38.e328. J Korean Med Sci. 2023. PMID: 37873628 Free PMC article.
343 results